These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 17011541

  • 1. Determination of everolimus in whole blood using the Abbott IMx sirolimus microparticle enzyme immunoassay.
    Bouzas L, Tutor JC.
    Clin Biochem; 2007 Jan; 40(1-2):132-6. PubMed ID: 17011541
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Relationship between everolimus blood concentration assessed using the Innofluor Certican Fluorescence Polarization Immunoassay and the Architect i System sirolimus chemiluminescent microparticle immunoassay.
    Coentrão L, Carvalho C, Sampaio S, Oliveira JG, Pestana MI.
    Transplant Proc; 2010 Jun; 42(5):1867-9. PubMed ID: 20620539
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of the reintroduced MEIA assay with HPLC-MS/MS for the determination of whole-blood sirolimus from transplant recipients.
    Morris RG, Salm P, Taylor PJ, Wicks FA, Theodossi A.
    Ther Drug Monit; 2006 Apr; 28(2):164-8. PubMed ID: 16628125
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Crossreactivity of isolated everolimus metabolites with the Innofluor Certican immunoassay for therapeutic drug monitoring of everolimus.
    Strom T, Haschke M, Boyd J, Roberts M, Arabshahi L, Marbach P, Christians U.
    Ther Drug Monit; 2007 Dec; 29(6):743-9. PubMed ID: 18043471
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of the hematocrit and its correction on the relationship between blood tacrolimus concentrations obtained using the microparticle enzyme immunoassay (MEIA) and enzyme multiplied immunoassay technique (EMIT).
    Bouzas L, Ortega FJ, Casado P, Arranz MI, Carcas A, Tutor JC.
    Clin Lab; 2007 Dec; 53(9-12):591-6. PubMed ID: 18257466
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Liquid chromatography-tandem mass spectrometry outperforms fluorescence polarization immunoassay in monitoring everolimus therapy in renal transplantation.
    Moes DJ, Press RR, de Fijter JW, Guchelaar HJ, den Hartigh J.
    Ther Drug Monit; 2010 Aug; 32(4):413-9. PubMed ID: 20535052
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of a new immunoassay to measure sirolimus blood concentrations compared to a tandem mass-spectrometric chromatographic analysis.
    Fillée C, Mourad M, Squifflet JP, Malaise J, Lerut J, Reding R, Borghgraef P, Vanbinst R, Wallemacq PE.
    Transplant Proc; 2005 Aug; 37(6):2890-1. PubMed ID: 16182845
    [Abstract] [Full Text] [Related]

  • 18. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
    Akbas SH, Ozdem S, Caglar S, Tuncer M, Gurkan A, Yucetin L, Senol Y, Demirbas A, Gultekin M, Ersoy FF, Akaydin M.
    Clin Biochem; 2005 Jun; 38(6):552-7. PubMed ID: 15885236
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.